Eva Garland Consulting (EGC)’s unique expertise in science and accounting has supported innovators in leveraging over $2 billion in funding for transformative technologies.
Trending
EGC February Newsletter
This month, EGC highlights our client Kernal Biologics and their $48M ARPA-H award advancing next-generation cell therapies, shares a 2026 compliance and tax deadline checklist from our Accounting & Compliance team, and features a roundup of current and upcoming funding opportunities from ARPA-H, NIH, DOW, NASA, and more.
A New Year Checklist: Key Compliance and Tax Deadlines for 2026
The new year is when many early-stage companies discover how quickly accounting, tax, and compliance requirements can escalate in priority—especially in research-driven and federally funded environments. Here are some key dates to keep in mind for organizations with a December 31st fiscal year-end. Early planning for these deadlines can help avoid surprises and ensure smoother operations as the year gets underway.
Press Release — 1300+ Small Business Leaders Sign Letter to Congress
Over 1,300 CEOs and innovation leaders representing all 50 states, Washington, DC, and Puerto Rico are calling for immediate Congressional action to reauthorize the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs.
Watch Now — 101 Ways to Reposition Your NIH SBIR/STTR Proposal
In this session, Dr. Eva Garland and Dr. Angie Pollard share practical strategies for repositioning NIH SBIR/STTR proposals to pursue a broader range of non-dilutive funding opportunities—including other NIH mechanisms, other federal agencies such as DOD, ARPA-H, and BARDA, private foundations, and more.
Read Now — Expanding Funding Pathways for Life Science Innovators
To help you uncover new pathways for funding support, Scientific Grants Expert Brandon Turner, Ph.D., highlights several “out-of-the-box” opportunities beyond traditional mechanisms—options that can broaden your funding strategy and accelerate your scientific advancement.
Watch Now—Webinar and Open Q&A Session for Recent SBIR/STTR Awardees
In this session, CEO, Eva Garland, Ph.D., and VP of Accounting & Compliance, Jeremy Hinckley, CPA, MBA, guide attendees through the essential requirements for new SBIR/STTR awards and provide real-time answers to common compliance questions. Viewers will gain clarity on timekeeping, project cost accounting, and policy & procedures development to ensure their projects stay on track.
Recent News
January 29, 2026
A New Year Checklist: Key Compliance and Tax Deadlines for 2026
Here are some key dates to keep in mind for organizations with a December 31st fiscal year-end. Early planning for these deadlines can help avoid…
January 15, 2026
1300+ Small Business Leaders Sign Letter to Congress
Over 1,300 CEOs and innovation leaders representing all 50 states, Washington, DC, and Puerto Rico are calling for immediate Congressional action to…
November 26, 2025
Casting a Wider Net: Expanding Funding Pathways for Life Science Innovators
By broadening the set of agencies, programs, and partnerships you consider, you can diversify funding sources, reduce vulnerability to individual…
November 5, 2025
Powering Cardiovascular Innovation
September 16, 2025
New Book Release—Winning NSF SBIR/STTR Grants!
April 1, 2025
Webinar: Navigating the Impact of Current Government Policies on the Non-Dilutive Funding Landscape
With deep expertise in non-dilutive funding, Dr. Garland provided expert guidance on how the changing government funding environment has been shaping…
Recent News
January 29, 2026
A New Year Checklist: Key Compliance and Tax Deadlines for 2026
Here are some key dates to keep in mind for organizations with a December 31st fiscal year-end. Early planning for these deadlines can help avoid…
January 15, 2026
1300+ Small Business Leaders Sign Letter to Congress
Over 1,300 CEOs and innovation leaders representing all 50 states, Washington, DC, and Puerto Rico are calling for immediate Congressional action to…
November 26, 2025
Casting a Wider Net: Expanding Funding Pathways for Life Science Innovators
By broadening the set of agencies, programs, and partnerships you consider, you can diversify funding sources, reduce vulnerability to individual…
November 5, 2025
Powering Cardiovascular Innovation
September 16, 2025
New Book Release—Winning NSF SBIR/STTR Grants!
April 1, 2025
Webinar: Navigating the Impact of Current Government Policies on the Non-Dilutive Funding Landscape
With deep expertise in non-dilutive funding, Dr. Garland provided expert guidance on how the changing government funding environment has been shaping…
Client Highlights
Boston Metal
Boston Metal received a $50 million grant from the U.S. Department of Energy’s (DOE) Advanced Energy Manufacturing and Recycling Grants Program.
Laser Thermal
Laser Thermal has secured an Air Force SBIR Phase I award ($150K), a DARPA SBIR Direct to Phase II award ($2M), and an Army STTR Phase I ($250K).
Ascent Integrated Tech
Securing over $2.8M in funding, Ascent Integrated Tech developed a system to monitor firefighters' health and environment.
AgroSpheres
AgroSpheres, a company specializing in degrading pesticide residues on plants, has secured over $30 million in federal grants and multiple investor funding rounds.
FaceView Mask
FaceView Mask secured Phase I and II STTR awards, enabling clinical trials and the successful commercialization of a KN95 mask with a clear window.
Scioto Biosciences
Scioto Biosciences secures >$2.5M in NIH funding, attracting a $26.5M Series B investment.
Bezwada Biomedical
Bezwada Biomedical has secured $1.225 M from NSF to advance their bioabsorbable surgical tissue adhesive, TissuBond™.
Boston Metal
Boston Metal received a $50 million grant from the U.S. Department of Energy’s (DOE) Advanced Energy Manufacturing and Recycling Grants Program.
Laser Thermal
Laser Thermal has secured an Air Force SBIR Phase I award ($150K), a DARPA SBIR Direct to Phase II award ($2M), and an Army STTR Phase I ($250K).
Ascent Integrated Tech
Securing over $2.8M in funding, Ascent Integrated Tech developed a system to monitor firefighters' health and environment.
AgroSpheres
AgroSpheres, a company specializing in degrading pesticide residues on plants, has secured over $30 million in federal grants and multiple investor funding rounds.
FaceView Mask
FaceView Mask secured Phase I and II STTR awards, enabling clinical trials and the successful commercialization of a KN95 mask with a clear window.
Scioto Biosciences
Scioto Biosciences secures >$2.5M in NIH funding, attracting a $26.5M Series B investment.
Bezwada Biomedical
Bezwada Biomedical has secured $1.225 M from NSF to advance their bioabsorbable surgical tissue adhesive, TissuBond™.
Our Clients Have Secured
$1,991,689,721
In Non-dilutive Funding
“Our team from EGC has been extremely prompt, professional, and knowledgeable. We were considering hiring a part time administrator to help with grants management and book-keeping, but EGC has been able to provide that service with more expertise, and they do so more efficiently. I highly recommend them!”
Brian Lawson, Co-Founder
“Incredible grant writers and business-minded team! I continue to be impressed with the breadth of grant knowledge and experience that the EGC team brings to the table. I have worked with an EGC consultant on numerous grants and am so grateful for his time and effort. You will not regret the decision to work with EGC for your next federal grant application!”
Alli Truttmann, CEO & Founder
“Our company exists today because of EGC. As cost intensive as biotech is, and reticent it is to fund new science (unchartered), we’ve had to rely on any and every resource available to keep WinSanTor alive. We are now about to enter phase 3 as the first and only company regrowing and repairing peripheral nerve damage (aka peripheral neuropathy), and Eva and her team were there every step of the way. They helped us turn over every rock, and with their help, we’ve received tens of millions of dollars of funding that literally kept the company afloat. They have an amazing team, which we now consider part of our own company as far as desire and commitment.”
Stanley Kim, Co-Founder & CEO
“All around EXCELLENT! Excellent collaboration, excellent communication, and top-notch knowledge of the process. We submitted a massive ARPA-H grant, and we absolutely could not have done it without the assistance of Eva Garland Consulting.”
Joel Moore, Senior Vice President of Non-Clinical Development
“The EGC team is highly professional and keeps everything on track as it relates to accounting for federal grants.”













































































